START (South Texas Accelerated Research Therapeutics)

San Antonio, Texas 78229

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Oncology Clinical Trial
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab in Subjects With Advanced GI Tumors (Keynote 596)
Status: Enrolling, Phase I
Updated: 12/31/1969
START (South Texas Accelerated Research Therapeutics)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
START (South Texas Accelerated Research Therapeutics)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Solid Tumor, Adult Clinical Trial
Study of ASTX029 in Subjects With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
START (South Texas Accelerated Research Therapeutics)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
PRS-343 in HER2-Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
START (South Texas Accelerated Research Therapeutics)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Advanced Malignancies Clinical Trial
A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas
Status: Enrolling, Phase I
Updated: 12/31/1969
START (South Texas Accelerated Research Therapeutics)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Solid Tumor Clinical Trial
Crossover Study to Assess the Relative Bioavailability of Niraparib Tablet Compared to Niraparib Capsule
Status: Enrolling, Phase I
Updated: 3/9/2018
START (South Texas Accelerated Research Therapeutics)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Status: Enrolling, Phase IV
Updated: 12/31/1969
START (South Texas Accelerated Research Therapeutics)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Advanced Malignancies Clinical Trial
Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study
Status: Upcoming, Phase I
Updated: 8/10/2015
START (South Texas Accelerated Research Therapeutics)
mi
from
San Antonio, TX
Click here to add this to my saved trials